Ethical Compliance
NATCO PHARMA.
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
medium
Revenue
2.5%
Debt
5.3%
Liquidity
13.8%
Revenue
Debt
Liquidity
2.5%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Services | ₹353.30 |
| Sale of Products - Pharma | ₹3,624.60 |
| Job Work Income | ₹0.90 |
| Other Operating Revenues | ₹20.00 |
| Other Income | ₹26.40 |
Questionable
INR Crores
| Investment Gain | ₹0.70 |
Non Compliant
INR Crores
| Interest Income | ₹101.00 |
INR Crores
| Revenue from Questionable Sources: | ₹0.70 |
| Revenue from Non Compliant Sources: | ₹101.00 |
| Total: | ₹101.70 |
| Total Revenue: | ₹4,126.90 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹101.70
₹4,126.90
= 2.5%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
